Form 4 for BDSX BIODESIX INC
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-08 · accession 0000905148-24-003057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-13 | 2024-11-08 | BDSX | O'Kane Kieran | Chief Commercial Off | M - OptEx | — | +1,490 | 97.9K | +2% | — |
| DM | 2024-11-13 | 2024-11-11+ | BDSX | O'Kane Kieran | Chief Commercial Off | S - Sale+OE | $1.39 | -462 | 97.4K | -0.5% | -$644.42 |
| D | 2024-11-13 | 2024-11-08 | BDSX | O'Kane Kieran | Chief Commercial Off | M - OptEx | $0.00 | -1,490 | 7,447 | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-08 | M | A | 1,490 | — | 97,910 | D | — | — | (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) Includes 6,792 shares purchased under the Issuer's Employee Stock Purchase Plan on August 30, 2024. |
| 2 | Common | Common Stock | 2024-11-11 | S | D | 238 | $1.39 | 97,672 | D | — | — | (F4) The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.36 to $1.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-11-12 | S | D | 224 | $1.40 | 97,448 | D | — | — | (F5) The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Restricted Stock Units | 2024-11-08 | M | D | 1,490 | $0.00 | 7,447 | D | — · — to — | 1,490 Common Stock | (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F6) These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |